Alginate Improves the Chondrogenic Capacity of 3D PCL Scaffolds In Vitro: A Histological Approach

Lara Milián,María Oliver-Ferrándiz,Ignacio Peregrín,María Sancho-Tello,José Javier Martín-de-Llano,Cristina Martínez-Ramos,Carmen Carda,Manuel Mata

DOI: https://doi.org/10.3390/cimb46040223

2024-04-19

Current Issues in Molecular Biology

Abstract:Polycaprolactone (PCL) scaffolds have demonstrated an effectiveness in articular cartilage regeneration due to their biomechanical properties. On the other hand, alginate hydrogels generate a 3D environment with great chondrogenic potential. Our aim is to generate a mixed PCL/alginate scaffold that combines the chondrogenic properties of the two biomaterials. Porous PCL scaffolds were manufactured using a modified salt-leaching method and embedded in a culture medium or alginate in the presence or absence of chondrocytes. The chondrogenic capacity was studied in vitro. Type II collagen and aggrecan were measured by immunofluorescence, cell morphology by F-actin fluorescence staining and gene expression of COL1A1, COL2A1, ACAN, COL10A1, VEGF, RUNX1 and SOX6 by reverse transcription polymerase chain reaction (RT-PCR). The biocompatibility of the scaffolds was determined in vivo using athymic nude mice and assessed by histopathological and morphometric analysis. Alginate improved the chondrogenic potential of PCL in vitro by increasing the expression of type II collagen and aggrecan, as well as other markers related to chondrogenesis. All scaffolds showed good biocompatibility in the in vivo model. The presence of cells in the scaffolds induced an increase in vascularization of the PCL/alginate scaffolds. The results presented here reinforce the benefits of the combined use of PCL and alginate for the regeneration of articular cartilage.

biochemistry & molecular biology

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve

This paper aims to address key issues in articular cartilage regeneration. Specifically, the researchers hope to develop a hybrid scaffold combining polycaprolactone (PCL) and sodium alginate to enhance its chondrogenic capacity. PCL scaffolds are widely used in articular cartilage regeneration due to their biomechanical properties, while sodium alginate hydrogels can provide a three-dimensional environment that promotes chondrocyte proliferation and differentiation. By combining these two materials, the researchers hope to create a scaffold that maintains the biomechanical properties of the injured cartilage while providing a favorable environment for cartilage generation.

### Research Background

Articular cartilage is a special type of connective tissue that can resist compressive forces, mainly distributed on the joint surface, playing a role in absorbing and dispersing tension and pressure, thus protecting the underlying bone tissue. However, the regenerative capacity of articular cartilage is very limited, with its nutrition mainly coming from synovial fluid and lacking blood vessels and peripheral cartilage membrane. These characteristics make it difficult for articular cartilage to self-repair after injury. Existing treatments such as drilling, abrasion arthroplasty, and microfracture are effective for small-scale injuries but are less effective for larger injuries, often resulting in the formation of fibrocartilage, which cannot meet the stringent biomechanical requirements of articular cartilage, leading to chronic inflammation and even loss of joint function.

### Research Objectives

The main objective of this paper is to generate a hybrid scaffold composed of a porous PCL scaffold embedded in sodium alginate hydrogel and to evaluate its chondrogenic capacity in vitro and biocompatibility in vivo. To this end, the researchers constructed an in vitro chondrogenic differentiation model based on previous research findings and evaluated the biocompatibility of the scaffold in a subcutaneous implantation model in athymic nude mice.

### Main Methods

1. **Preparation and Characterization of PCL Scaffolds**:
- Manufacture porous PCL scaffolds using a modified salt leaching method.
- The porosity of the scaffolds is 60-85%, with a pore size of approximately 200 μm and an elastic modulus of about 5 MPa.

2. **Preparation of Hybrid PCL-Sodium Alginate Scaffolds**:
- Prepare a 3% sodium alginate solution.
- Embed the PCL scaffold in the sodium alginate solution with or without chondrocytes.

3. **Cell Isolation and Culture**:
- Obtain articular cartilage samples from patients undergoing arthroscopy, isolate and culture primary chondrocytes.
- Expand cells using DMEM medium containing 10% fetal bovine serum.

4. **Immunofluorescence Staining**:
- Detect the expression of type II collagen and aggrecan.

5. **F-actin Fluorescence Staining**:
- Observe cell morphology.

6. **Gene Expression Analysis**:
- Use real-time RT-PCR to detect the expression of chondrogenesis-related genes such as COL1A1, COL2A1, ACAN, COL10A1, VEGF, RUNX1, and SOX6.

7. **In Vivo Experiments**:
- Implant PCL scaffolds subcutaneously in athymic nude mice to evaluate their biocompatibility and vascularization.

### Results

The results showed that sodium alginate significantly enhanced the chondrogenic capacity of PCL scaffolds, increasing the expression of type II collagen and aggrecan, as well as other chondrogenesis-related markers. All scaffolds exhibited good biocompatibility in the in vivo model, and the PCL/sodium alginate scaffolds containing cells also induced increased vascularization. These results suggest that the combined use of PCL and sodium alginate has potential advantages in articular cartilage regeneration.

### Conclusion

This study successfully generated a hybrid scaffold combining PCL and sodium alginate, which exhibited excellent chondrogenic capacity and good biocompatibility in vitro. These findings provide new strategies for articular cartilage regeneration and may play an important role in future clinical applications.